Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add filters








Year range
1.
Indian J Dermatol Venereol Leprol ; 2004 May-Jun; 70(3): 172-4
Article in English | IMSEAR | ID: sea-52666

ABSTRACT

Non-Hodgkin's lymphoma (NHL) belongs to a group of lymphoid neoplasms that is diverse in manner of presentation, response to therapy and prognosis. Usually the oral manifestations of NHL are secondary to a more widespread involvement throughout the body. Though primary intraoral lesions in NHL are uncommon, it is important to be aware of them, since intraoral manifestations are the presenting symptom in these patients. A 55 year old woman presented with a swelling in the maxillary right alveolus and buccal vestibule. There were no palpable lymph nodes. A CT scan revealed a mass on the labial aspect of the right maxilla with no involvement of the maxillary sinus. Incisional biopsy of the lesion showed a dense lymphocytic infiltrate with formation of variably sized lymphoid follicles. The infiltrate showed a mixed neoplastic lymphocyte composition which was suggestive of follicular mixed type of malignant B cell primary extranodal lymphoma. The patient was treated with chemotherapy followed by radiation.

2.
Indian J Dermatol Venereol Leprol ; 2003 Jul-Aug; 69(4): 289-90
Article in English | IMSEAR | ID: sea-52968

ABSTRACT

A 54-year-old man, a road layer by occupation, presented with a 'leonine facies' and multiple tumors that were more commonly present over the exposed parts of the body. On investigation, he turned out to be a case of primary cutaneous B cell lymphoma with a distinctive histopathology. Chemotherapy was given with a good therapeutic response.

3.
Indian J Dermatol Venereol Leprol ; 2003 Jul-Aug; 69(4): 271-3
Article in English | IMSEAR | ID: sea-52794

ABSTRACT

INTRODUCTION: Acne vulgaris is commonly treated with topical antibacterials. We evaluated lincomycin gel, a new topical formulation for mild to moderate acne. MATERIAL AND METHODS: A multicentric, randomized, double blind, placebo controlled, clinical trial was conducted with lincomycin hydrochloride in 2% gel form in 200 patients with grade II and grade III acne. The severity of acne lesions was noted at baseline and after 4 weeks. RESULTS: About 70% cases in the study group showed a good to excellent response, which was significantly more as compared to 23% in the placebo group. The frequency and severity of adverse reactions in the two groups were similar. CONCLUSION: Lincomycin hydrochloride gel is an effective and safe treatment option for mild to moderate acne vulgaris.

4.
Indian J Dermatol Venereol Leprol ; 2002 Jul-Aug; 68(4): 234-5
Article in English | IMSEAR | ID: sea-52601

ABSTRACT

A case of asymptomatic multiple leiomyoma along with its histopathological features is described.

5.
Indian J Dermatol Venereol Leprol ; 2002 Jul-Aug; 68(4): 236-7
Article in English | IMSEAR | ID: sea-52015

ABSTRACT

A case of eccrine spiradenoma, an uncommon tumour, in an adult woman is described herewith its clinical and histopathological features.

6.
Indian J Dermatol Venereol Leprol ; 2001 Jan-Feb; 67(1): 44-5
Article in English | IMSEAR | ID: sea-52640

ABSTRACT

Tufted angiomas are rare benign tumours with a characteristic histopathological appearance. Their occurrence in neurofibromatosis type 1, a genodermatosis in which vascular malformations are not uncommon, has hitherto not been reported. Some of the characteristic features of tufted angiomas are discussed.

7.
J Indian Med Assoc ; 2000 Apr; 98(4): 194-5
Article in English | IMSEAR | ID: sea-102706

ABSTRACT

The aim of the present post marketing study was to study the safety and efficacy of supirocin-B ointment (mupirocin 2% + betamethasone dipropionate 0.05%) in the treatment of infected dermatoses. For this purpose physicians from different parts of India were requested to keep the clinical records prospectively as per a specially designed proforma over a follow-up period of 7 days, whenever they prescribed supirocin-B ointment (mupirocin 2% + betamethasone dipropionate 0.05%) for local application, three times a day, to their patients having either primary infection complicated by dermatoses or dermatoses infected secondarily. From the analysis of 251 clinical records contributed by 27 physicians, it was evident that in clinical practice, supirocin-B ointment (mupirocin 2% + betamethasone dipropionate 0.05%) was found to be safe and very effective by physicians in the treatment of infected dermatoses in 94.8% of the patients. Similarly 92.4% of the patients reported more than 70% improvement in their symptoms after 7 days of treatment. No adverse effects were reported during the treatment period by any of the patients except worsening of skin lesions by one patient. Thus from this study, supirocin-B ointment (mupirocin 2% + betamethasone dipropionate 0.05%) seems to be safe and effective in the treatment of infected dermatoses.


Subject(s)
Betamethasone/administration & dosage , Drug Combinations , Humans , India , Mupirocin/administration & dosage , Ointments , Product Surveillance, Postmarketing , Pyoderma/drug therapy , Staphylococcal Skin Infections/drug therapy , Streptococcal Infections/drug therapy , Treatment Outcome
10.
Indian J Pediatr ; 1981 Nov-Dec; 48(395): 781-3
Article in English | IMSEAR | ID: sea-83197
12.
14.
Indian Pediatr ; 1979 Jul; 16(7): 655-7
Article in English | IMSEAR | ID: sea-13492
SELECTION OF CITATIONS
SEARCH DETAIL